Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 3.030
-0.010 (-0.33%)
Oct 22, 2026, 11:10 AM CEST
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 116.06 million as of October 21, 2026. It is the 22,940th most valuable company in the world and the 177th biggest in Switzerland. Its market cap has increased by 8.91% in one year.
Market Cap
116.06M
Enterprise Value
51.18M
Revenue
n/a
Global Rank
Country Rank
#177 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 116.06M, a decrease of -72.76%. That is a compound annual growth rate of -10.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 116.06M | -8.32% |
| Dec 30, 2025 | 126.60M | -15.41% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.44B |
| Idorsia | 1.14B |
| Basilea Pharmaceutica AG | 838.38M |
| Santhera Pharmaceuticals Holding AG | 224.94M |
| Newron Pharmaceuticals | 180.53M |
| BioVersys AG | 143.11M |
| Xlife Sciences AG | 52.25M |
| MindMaze Therapeutics Holding | 25.33M |